| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 157, Issue 12 5240-5248, Copyright © 1996 by American Association of Immunologists
ARTICLES |
WW Cruikshank, K Lim, AC Theodore, J Cook, G Fine, PF Weller and DM Center
The Pulmonary Center, Boston University School of Medicine, MA 02118, USA.
We have recently described the cDNA and predicted protein structure of a natural soluble CD4 ligand, IL-16. IL-16 is chemotactic for CD4+ T cells and induces functional IL-2 receptors in CD4+ T cells. The binding of IL-16 to CD4 results in activation of p56(lck), whose adaptor function is essential for the chemotactic response. Subsequently, increases in intracellular Ca2+ and phosphatidylinositol 1,4,5-trisphosphate occur, as does translocation of protein kinase C from cytosol to membrane. Because of the similarities between these signals and functions and those noted for the CD4 ligand HIV-1 gp120, we investigated the potential regulatory effects of IL-16 on CD3/TCR- mediated lymphocyte activation. Preincubation of human T cells with IL- 16 up to 24 h before activation with plate-bound anti-CD3 Abs reduced T cell activation by 80%, as monitored by IL-2R expression and [3H]thymidine uptake. If IL-16 was added following anti-CD3 activation, no suppression was noted. The suppressive effects of preincubation with IL-16 were not rescued by the addition of rIL-2 and were not the result of priming for anti-CD3-induced apoptosis. In addition, IL-16 had no effect on surface expression of CD3 or CD4. However, IL-16 did reduce the magnitude of the anti-CD3-induced intracellular Ca2+ increase. These studies indicate that while the interaction of CD4 with its natural ligand, IL-16, results in Ag-independent chemotaxis and IL-2R expression, this pro-inflammatory state is associated with subsequent transient inhibition of responsiveness via the CD3/TCR complex.
This article has been cited by other articles:
|
|
 |
|
  C. McFadden, R. Morgan, S. Rahangdale, D. Green, H. Yamasaki, D. Center, and W. Cruikshank Preferential Migration of T Regulatory Cells Induced by IL-16 J. Immunol., November 15, 2007; 179(10): 6439 - 6445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Mannie and D. J. Abbott A Fusion Protein Consisting of IL-16 and the Encephalitogenic Peptide of Myelin Basic Protein Constitutes an Antigen-Specific Tolerogenic Vaccine That Inhibits Experimental Autoimmune Encephalomyelitis J. Immunol., August 1, 2007; 179(3): 1458 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Wendt, E. Wilk, S. Buyny, J. Buer, R. E. Schmidt, and R. Jacobs Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells J. Leukoc. Biol., December 1, 2006; 80(6): 1529 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Garg, I. J. Juncadella, N. Ramamoorthi, Ashish, S. K. Ananthanarayanan, V. Thomas, M. Rincon, J. K. Krueger, E. Fikrig, C. M. Yengo, et al. Cutting Edge: CD4 Is the Receptor for the Tick Saliva Immunosuppressor, Salp15 J. Immunol., November 15, 2006; 177(10): 6579 - 6583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. Gianoukakis, R. S. Douglas, C. S. King, W. W. Cruikshank, and T. J. Smith Immunoglobulin G from Patients with Graves' Disease Induces Interleukin-16 and RANTES Expression in Cultured Human Thyrocytes: A Putative Mechanism for T-Cell Infiltration of the Thyroid in Autoimmune Disease Endocrinology, April 1, 2006; 147(4): 1941 - 1949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Elssner, A. I. Doseff, M. Duncan, M. Kotur, and M. D. Wewers IL-16 Is Constitutively Present in Peripheral Blood Monocytes and Spontaneously Released During Apoptosis J. Immunol., June 15, 2004; 172(12): 7721 - 7725. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Kaminski, S. Kadereit, R. E. Miller, P. Leahy, K. R. Stein, D. A. Topa, T. Radivoyevitch, M. L. Veigl, and M. J. Laughlin Reduced expression of NFAT-associated genes in UCB versus adult CD4+ T lymphocytes during primary stimulation Blood, December 15, 2003; 102(13): 4608 - 4617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Xu, P. B. Silver, T. K. Tarrant, C.-C. Chan, and R. R. Caspi TGF-{beta} Inhibits Activation and Uveitogenicity of Primary but Not of Fully Polarized Retinal Antigen-Specific Memory-Effector T Cells Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4805 - 4812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Gianoukakis, L. J. Martino, N. Horst, W. W. Cruikshank, and T. J. Smith Cytokine-Induced Lymphocyte Chemoattraction from Cultured Human Thyrocytes: Evidence for Interleukin-16 and Regulated upon Activation, Normal T Cell Expressed, and Secreted Expression Endocrinology, July 1, 2003; 144(7): 2856 - 2864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Magrangeas, V. Nasser, H. Avet-Loiseau, B. Loriod, O. Decaux, S. Granjeaud, F. Bertucci, D. Birnbaum, C. Nguyen, J.-L. Harousseau, et al. Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease Blood, June 15, 2003; 101(12): 4998 - 5006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. F. Little, E. Lynch, G. Fine, D. M. Center, and W. W. Cruikshank Tumor Necrosis Factor-{alpha}-Induced Synthesis of Interleukin-16 in Airway Epithelial Cells: Priming for Serotonin Stimulation Am. J. Respir. Cell Mol. Biol., March 1, 2003; 28(3): 354 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bandeira-Melo, K. Sugiyama, L. J. Woods, M. Phoofolo, D. M. Center, W. W. Cruikshank, and P. F. Weller IL-16 Promotes Leukotriene C4 and IL-4 Release from Human Eosinophils via CD4- and Autocrine CCR3-Chemokine-Mediated Signaling J. Immunol., May 1, 2002; 168(9): 4756 - 4763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Spender, G. H. Cornish, A. Sullivan, and P. J. Farrell Expression of Transcription Factor AML-2 (RUNX3, CBF{alpha}-3) Is Induced by Epstein-Barr Virus EBNA-2 and Correlates with the B-Cell Activation Phenotype J. Virol., April 16, 2002; 76(10): 4919 - 4927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chavan, S. Kodoth, R. Pahwa, and S. Pahwa The HIV protease inhibitor Indinavir inhibits cell-cycle progression in vitro in lymphocytes of HIV-infected and uninfected individuals Blood, July 15, 2001; 98(2): 383 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Strong, Q. Wang, and N. Killeen Impaired survival of T helper cells in the absence of CD4 PNAS, February 15, 2001; (2001) 51329698. [Abstract] [Full Text]
|
|
|
|
|
|
C. Van Drenth, A. Jenkins, L. Ledwich, T. C. Ryan, M. V. Mashikian, W. Brazer, D. M. Center, and W. W. Cruikshank Desensitization of CXC Chemokine Receptor 4, Mediated by IL-16/CD4, Is Independent of p56lck Enzymatic Activity J. Immunol., December 1, 2000; 165(11): 6356 - 6363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Badley, A. A. Pilon, A. Landay, and D. H. Lynch Mechanisms of HIV-associated lymphocyte apoptosis Blood, November 1, 2000; 96(9): 2951 - 2964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kaser, S. Dunzendorfer, F. A. Offner, O. Ludwiczek, B. Enrich, R. O. Koch, W. W. Cruikshank, C. J. Wiedermann, and H. Tilg B Lymphocyte-Derived IL-16 Attracts Dendritic Cells and Th Cells J. Immunol., September 1, 2000; 165(5): 2474 - 2480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yoshimoto, C.-R. Wang, T. Yoneto, A. Matsuzawa, W. W. Cruikshank, and H. Nariuchi Role of IL-16 in delayed-type hypersensitivity reaction Blood, May 1, 2000; 95(9): 2869 - 2874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sciaky, W. Brazer, D. M. Center, W. W. Cruikshank, and T. J. Smith Cultured Human Fibroblasts Express Constitutive IL-16 mRNA: Cytokine Induction of Active IL-16 Protein Synthesis Through a Caspase-3-Dependent Mechanism J. Immunol., April 1, 2000; 164(7): 3806 - 3814. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Laan, I. Qvarfordt, G. C Riise, B. A Andersson, S. Larsson, and A. Lindén Increased levels of interleukin-16 in the airways of tobacco smokers: relationship with peripheral blood T lymphocytes Thorax, October 1, 1999; 54(10): 911 - 916. [Abstract] [Full Text]
|
|
|
|
|
|
M. V. Mashikian, T. C. Ryan, A. Seman, W. Brazer, D. M. Center, and W. W. Cruikshank Reciprocal Desensitization of CCR5 and CD4 Is Mediated by IL-16 and Macrophage-Inflammatory Protein-1{beta}, Respectively J. Immunol., September 15, 1999; 163(6): 3123 - 3130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Sanzenbacher, D. Kabelitz, and O. Janssen SLP-76 Binding to p56lck: A Role for SLP-76 in CD4-Induced Desensitization of the TCR/CD3 Signaling Complex J. Immunol., September 15, 1999; 163(6): 3143 - 3152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kaser, S. Dunzendorfer, F. A. Offner, T. Ryan, A. Schwabegger, W. W. Cruikshank, C. J. Wiedermann, and H. Tilg A Role for IL-16 in the Cross-Talk Between Dendritic Cells and T Cells J. Immunol., September 15, 1999; 163(6): 3232 - 3238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Bannert, A. Avots, M. Baier, E. Serfling, and R. Kurth GA-binding protein factors, in concert with the coactivator CREB binding protein/p300, control the induction of the interleukin 16 promoter in T lymphocytes PNAS, February 16, 1999; 96(4): 1541 - 1546. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Chupp, E. A. Wright, D. Wu, M. Vallen-Mashikian, W. W. Cruikshank, D. M. Center, H. Kornfeld, and J. S. Berman Tissue and T Cell Distribution of Precursor and Mature IL-16 J. Immunol., September 15, 1998; 161(6): 3114 - 3119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Parada, D. M. Center, H. Kornfeld, W. L. Rodriguez, J. Cook, M. Vallen, and W. W. Cruikshank Synergistic Activation of CD4+ T Cells by IL-16 and IL-2 J. Immunol., March 1, 1998; 160(5): 2115 - 2120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zeitlmann, P. Sirim, E. Kremmer, and W. Kolanus Cloning of ACP33 as a Novel Intracellular Ligand of CD4 J. Biol. Chem., March 16, 2001; 276(12): 9123 - 9132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Strong, Q. Wang, and N. Killeen Impaired survival of T helper cells in the absence of CD4 PNAS, February 27, 2001; 98(5): 2566 - 2571. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
